Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,090 | 13,380 | 140 | -4,780 | -1,560 |
| Depreciation Amortization | 1,900 | 2,040 | 2,230 | 7,450 | 1,810 |
| Other Working Capital | 350 | 1,220 | -110 | -9,180 | 2,390 |
| Other Operating Activity | 2,420 | -13,120 | 4,110 | 17,140 | 1,670 |
| Operating Cash Flow | $580 | $3,520 | $6,370 | $10,630 | $4,310 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -390 | -660 | -310 | -1,760 | -440 |
| Net Acquisitions | -90 | -110 | -22,400 | -41,170 | -1,950 |
| Other Investing Activity | 1,330 | -100 | -8,700 | 9,410 | -4,720 |
| Investing Cash Flow | $850 | $-870 | $-31,410 | $-33,520 | $-7,110 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -6,190 | -2,660 | 25,890 | 28,100 | -2,660 |
| Financing Cash Flow | $-6,190 | $-2,660 | $25,890 | $28,100 | $-2,660 |
| Exchange Rate Effect | -830 | -1,060 | -810 | -130 | -320 |
| Beginning Cash Position | 23,470 | 23,310 | 28,530 | 18,620 | 26,560 |
| End Cash Position | 17,890 | 22,240 | 28,580 | 23,700 | 20,780 |
| Net Cash Flow | $-5,580 | $-1,070 | $40 | $5,080 | $-5,780 |
| Free Cash Flow | |||||
| Operating Cash Flow | 580 | 3,520 | 6,370 | 10,630 | 4,310 |
| Free Cash Flow | 580 | 3,520 | 6,370 | 10,630 | 4,310 |